We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
New year, new leader on the pharma TV ad spending board. In January, Pfizer’s Xeljanz topped AbbVie's Humira in a rare bypass of the usual No. 1, spending more than $40 million on national TV time.